The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| NNOX | -33.61% | -86.96% | -33.46% | -82% |
| S&P | +14.5% | +93.32% | +14.09% | +97% |
Nano-X Imaging Ltd. is engaged in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The firm operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Neve Ilan, Israel.
Nano-X has the FDA's backing. Now it just needs to make some money.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $3.04M | 12.6% |
| Gross Profit | -$3.34M | -13.1% |
| Gross Margin | -109.77% | -0.5% |
| Market Cap | $329.65M | -22.3% |
| Market Cap / Employee | $2.00M | 0.0% |
| Employees | 165 | 0.6% |
| Net Income | -$14.72M | -8.4% |
| EBITDA | -$11.46M | 0.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $49.90M | 27.9% |
| Accounts Receivable | $1.88M | 24.7% |
| Inventory | 2.3 | 135.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $3.73M | 1.3% |
| Short Term Debt | $4.23M | 4.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -29.30% | -2.0% |
| Return On Invested Capital | -29.86% | -59.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$10.47M | -13.8% |
| Operating Free Cash Flow | -$9.41M | -12.7% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 2.03 | 2.57 | 1.68 | 1.86 | -18.78% |
| Price to Sales | 33.37 | 38.38 | 27.67 | 27.80 | -33.87% |
| Price to Tangible Book Value | 3.56 | 4.62 | 2.67 | 3.00 | -24.20% |
| Enterprise Value to EBITDA | -27.39 | -30.54 | -23.68 | -25.00 | -22.30% |
| Return on Equity | -27.2% | -27.8% | -30.1% | -32.9% | 5.43% |
| Total Debt | $7.81M | $7.45M | $7.40M | $7.95M | 3.06% |
NNOX earnings call for the period ending December 31, 2024.
NNOX earnings call for the period ending September 30, 2024.
NNOX earnings call for the period ending June 30, 2024.
NNOX earnings call for the period ending March 31, 2024.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
